18 November 2024
18 November 2024
The reasons why one animal chooses one path over another, or behaves differently from others, can often seem enigmatic. But a team led by Claire Wyart’s group at the Paris Brain Institute (ICM), in collaboration with Michael Orger’s lab at the Champalimaud Foundation (CF), has shed light on these differences, revealing the dynamic relationship between an animal’s internal states and its surroundings.
18 November 2024
Parkinson's disease (PD) is a progressive neurological disorder known for its characteristic motor symptoms: tremor, rigidity, and slowness of movement. Among these, rest tremor—a shaking that occurs when muscles are relaxed—is one of the most recognisable yet least understood.
18 November 2024 – 12:00
Champalimaud Foundation Auditorium
The Roles of AI in Scientific Discovery: Our Experience Studying Collective Behavio
Gonzalo de Polavieja (Mathematics of Behavior and Intelligence Lab)
Molecular Characterization of Cancer by Spatial Pathology
Mireia Castillo-Martin (Molecular and Experimental Pathology Lab)
Moderator: Ana Luísa Correia (Cancer Dormancy and Immunity Lab)
30 October 2024
In order for our bodies to efficiently transform into fat the excess carbohydrates we eat, in a process of “lipogenesis”, two things must happen. First, the immune system's gamma-delta T cells, a type of lymphocytes that are present in large quantities in adipose tissue (a.k.a. fat), have to produce a substance that triggers lipogenesis, called IL-17.
16 October 2024
“I’m exactly as I was 10 years ago”, says Kina García, a Spanish woman from the Granada region, as she addresses by Zoom, from her home, the audience of the International Conference on Neurodegenerative Diseases, gathered on a Saturday morning at the Champalimaud Foundation’s auditorium, in Lisbon. The date is appropriate: it is September 21 – World Alzheimer's Day.